TAMPA, Florida – A Tampa-based company is currently working on a long-lasting COVID-19 vaccine that is not an injection into the arm.
The biotechnology company “Oragenics” is in the pre-clinical development of a COVID-19 vaccine that, according to them, would be easier to administer and last longer.
The vaccine COVID-19 would be in the form of a nasal spray. Instead of being injected into the muscle like current vaccines, the spray would go to the nose to protect against the virus, creating longer-lasting immunity.
The company says that the nasal spray would make the vaccine more accessible to all parts of the world, rather than having to be stored at low temperatures.
“The general idea is to have an easier method of delivery, especially for children and people who are afraid of needles. Or people who live in very remote areas of the world where it is difficult to try to get health professionals to do sterile injections.” said Dr. Alan Joslyn, CEO of Oragenics.
Oragenics is still in the development stage of their vaccine, but they hope to have it in clinical trials later this year.